AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 SEP 4 - (NewsRx.com & NewsRx.net) -- Celsion Corporation has obtained exclusive rights to an advanced phased array radio frequency (RF) heating system designed specifically for use with chemotherapeutic drugs for the treatment of locally advanced breast cancer.
Duke engineer, Thaddeus Samulski, PhD, developed the technology, which uses RF energy to warm a woman's breast to approximately 42 degrees C to enhance the effectiveness of liposomal chemotherapeutic compounds. During the treatment the breast is immersed in a pool of distilled water, which helps distribute the heat evenly around the breast, thus preventing skin burns and "hot spots," which often create pain. Skin burns and hot spots have, up to now, limited the use of RF hyperthermia as an effective means for treatment of breast cancer.
Patients who have undergone the treatment describe their experience as like having their breast immersed in a Jacuzzi.
The breast cancer treatment system is currently being clinically evaluated at Duke. A phase I trial has ...
Source: HighBeam Research, Duke University's hyperthermia treatment acquired.